Miss Rebecca Wallace

Overview

I'm a post-doctoral research associate in the Viral ImmunuTherapies and Advanced Therapeutics (VITAL) group, working on developing new cancer virotherapy platforms. I am currently funded by cancer Research Wales to develop viral vectors for the treatment of glioblastoma.

During my PhD, funded by CRUK and supervised by Professor Alan Parker, we developed new adenovirus-based vectors, which can be used as cancer therapies, gene-therapy- or vaccine vectors. I was and co-supervised by Dr Carly Bliss and Professor Awen Gallimore. In my thesis, titled "Development of Precision Virotherapies Capapble of Evading Neutralising Anti-Vector Immunity" I explored how population immunity to Ad5, the most commonly used Adenovirus vector, can be circumvented to better deliver therapies to patients.